nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—ORM1—Saquinavir—acquired immunodeficiency syndrome	0.0444	0.0683	CbGbCtD
Doxepin—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0188	0.0289	CbGbCtD
Doxepin—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0177	0.0272	CbGbCtD
Doxepin—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0173	0.0267	CbGbCtD
Doxepin—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0163	0.0251	CbGbCtD
Doxepin—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0163	0.0251	CbGbCtD
Doxepin—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.016	0.0246	CbGbCtD
Doxepin—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.016	0.0246	CbGbCtD
Doxepin—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0156	0.024	CbGbCtD
Doxepin—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0148	0.0227	CbGbCtD
Doxepin—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0147	0.0226	CbGbCtD
Doxepin—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0147	0.0226	CbGbCtD
Doxepin—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0143	0.022	CbGbCtD
Doxepin—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0143	0.0219	CbGbCtD
Doxepin—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0138	0.0212	CbGbCtD
Doxepin—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0134	0.0207	CbGbCtD
Doxepin—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0134	0.0207	CbGbCtD
Doxepin—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0134	0.0206	CbGbCtD
Doxepin—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0133	0.0204	CbGbCtD
Doxepin—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0133	0.0204	CbGbCtD
Doxepin—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0129	0.0198	CbGbCtD
Doxepin—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0124	0.019	CbGbCtD
Doxepin—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0122	0.0187	CbGbCtD
Doxepin—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0122	0.0187	CbGbCtD
Doxepin—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0121	0.0186	CbGbCtD
Doxepin—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0121	0.0186	CbGbCtD
Doxepin—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0116	0.0179	CbGbCtD
Doxepin—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0115	0.0176	CbGbCtD
Doxepin—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0112	0.0172	CbGbCtD
Doxepin—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0111	0.0171	CbGbCtD
Doxepin—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0111	0.0171	CbGbCtD
Doxepin—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0108	0.0166	CbGbCtD
Doxepin—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0105	0.0161	CbGbCtD
Doxepin—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0102	0.0157	CbGbCtD
Doxepin—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0101	0.0155	CbGbCtD
Doxepin—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0101	0.0155	CbGbCtD
Doxepin—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00978	0.015	CbGbCtD
Doxepin—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00978	0.015	CbGbCtD
Doxepin—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00966	0.0149	CbGbCtD
Doxepin—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00937	0.0144	CbGbCtD
Doxepin—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00921	0.0142	CbGbCtD
Doxepin—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00921	0.0142	CbGbCtD
Doxepin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00909	0.014	CbGbCtD
Doxepin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00855	0.0131	CbGbCtD
Doxepin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00855	0.0131	CbGbCtD
Doxepin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00773	0.0119	CbGbCtD
Doxepin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00773	0.0119	CbGbCtD
Doxepin—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00725	0.0111	CbGbCtD
Doxepin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00667	0.0103	CbGbCtD
Doxepin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00648	0.00996	CbGbCtD
Doxepin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00586	0.00901	CbGbCtD
Doxepin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00586	0.00901	CbGbCtD
Doxepin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00562	0.00864	CbGbCtD
Doxepin—ORM1—saliva—acquired immunodeficiency syndrome	0.00308	0.0469	CbGeAlD
Doxepin—HRH4—blood—acquired immunodeficiency syndrome	0.00166	0.0253	CbGeAlD
Doxepin—HRH4—bone marrow—acquired immunodeficiency syndrome	0.00161	0.0245	CbGeAlD
Doxepin—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00133	0.0202	CbGeAlD
Doxepin—DRD2—nerve—acquired immunodeficiency syndrome	0.00121	0.0184	CbGeAlD
Doxepin—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00114	0.0174	CbGeAlD
Doxepin—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00101	0.0154	CbGeAlD
Doxepin—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000947	0.0144	CbGeAlD
Doxepin—HRH2—skin of body—acquired immunodeficiency syndrome	0.000917	0.0139	CbGeAlD
Doxepin—CHRM5—skin of body—acquired immunodeficiency syndrome	0.000876	0.0133	CbGeAlD
Doxepin—HTR2A—nerve—acquired immunodeficiency syndrome	0.0008	0.0122	CbGeAlD
Doxepin—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000774	0.0118	CbGeAlD
Doxepin—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000734	0.0112	CbGeAlD
Doxepin—HRH2—digestive system—acquired immunodeficiency syndrome	0.000734	0.0112	CbGeAlD
Doxepin—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000711	0.0108	CbGeAlD
Doxepin—HRH2—blood—acquired immunodeficiency syndrome	0.000699	0.0106	CbGeAlD
Doxepin—CHRM4—nervous system—acquired immunodeficiency syndrome	0.000693	0.0105	CbGeAlD
Doxepin—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000681	0.0104	CbGeAlD
Doxepin—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.000668	0.0102	CbGeAlD
Doxepin—HTR6—nervous system—acquired immunodeficiency syndrome	0.000621	0.00944	CbGeAlD
Doxepin—HRH2—lung—acquired immunodeficiency syndrome	0.000613	0.00932	CbGeAlD
Doxepin—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000605	0.0092	CbGeAlD
Doxepin—HTR6—central nervous system—acquired immunodeficiency syndrome	0.000597	0.00909	CbGeAlD
Doxepin—HRH2—nervous system—acquired immunodeficiency syndrome	0.000567	0.00863	CbGeAlD
Doxepin—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00056	0.00852	CbGeAlD
Doxepin—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000551	0.00838	CbGeAlD
Doxepin—HRH2—central nervous system—acquired immunodeficiency syndrome	0.000546	0.00831	CbGeAlD
Doxepin—HTR2B—skin of body—acquired immunodeficiency syndrome	0.000545	0.00828	CbGeAlD
Doxepin—CHRM5—nervous system—acquired immunodeficiency syndrome	0.000542	0.00824	CbGeAlD
Doxepin—CHRM4—brain—acquired immunodeficiency syndrome	0.00053	0.00806	CbGeAlD
Doxepin—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.000522	0.00794	CbGeAlD
Doxepin—DRD2—retina—acquired immunodeficiency syndrome	0.000502	0.00764	CbGeAlD
Doxepin—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000495	0.00753	CbGeAlD
Doxepin—ORM1—blood—acquired immunodeficiency syndrome	0.000491	0.00747	CbGeAlD
Doxepin—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.000484	0.00737	CbGeAlD
Doxepin—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000477	0.00725	CbGeAlD
Doxepin—ORM1—bone marrow—acquired immunodeficiency syndrome	0.000476	0.00723	CbGeAlD
Doxepin—HTR6—brain—acquired immunodeficiency syndrome	0.000474	0.00721	CbGeAlD
Doxepin—ORM1—spinal cord—acquired immunodeficiency syndrome	0.000473	0.0072	CbGeAlD
Doxepin—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.000466	0.00709	CbGeAlD
Doxepin—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.00044	0.00669	CbGeAlD
Doxepin—HTR2B—digestive system—acquired immunodeficiency syndrome	0.000436	0.00662	CbGeAlD
Doxepin—HRH2—brain—acquired immunodeficiency syndrome	0.000434	0.0066	CbGeAlD
Doxepin—ORM1—lung—acquired immunodeficiency syndrome	0.000431	0.00655	CbGeAlD
Doxepin—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000426	0.00647	CbGeAlD
Doxepin—HRH2—lymph node—acquired immunodeficiency syndrome	0.000419	0.00637	CbGeAlD
Doxepin—SLC6A4—blood—acquired immunodeficiency syndrome	0.000419	0.00637	CbGeAlD
Doxepin—HTR2B—blood—acquired immunodeficiency syndrome	0.000415	0.00631	CbGeAlD
Doxepin—CHRM5—brain—acquired immunodeficiency syndrome	0.000414	0.0063	CbGeAlD
Doxepin—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000403	0.00614	CbGeAlD
Doxepin—ORM1—nervous system—acquired immunodeficiency syndrome	0.000399	0.00607	CbGeAlD
Doxepin—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000396	0.00603	CbGeAlD
Doxepin—CHRM3—digestive system—acquired immunodeficiency syndrome	0.000392	0.00596	CbGeAlD
Doxepin—HTR2B—vagina—acquired immunodeficiency syndrome	0.000385	0.00585	CbGeAlD
Doxepin—ORM1—central nervous system—acquired immunodeficiency syndrome	0.000384	0.00584	CbGeAlD
Doxepin—ADRA1B—brain—acquired immunodeficiency syndrome	0.000379	0.00576	CbGeAlD
Doxepin—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000372	0.00566	CbGeAlD
Doxepin—ADRA1D—brain—acquired immunodeficiency syndrome	0.00037	0.00563	CbGeAlD
Doxepin—SLC6A4—lung—acquired immunodeficiency syndrome	0.000367	0.00558	CbGeAlD
Doxepin—CHRM1—lung—acquired immunodeficiency syndrome	0.000366	0.00556	CbGeAlD
Doxepin—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000364	0.00554	CbGeAlD
Doxepin—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000364	0.00554	CbGeAlD
Doxepin—HTR2B—lung—acquired immunodeficiency syndrome	0.000364	0.00553	CbGeAlD
Doxepin—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000359	0.00545	CbGeAlD
Doxepin—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000358	0.00545	CbGeAlD
Doxepin—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000358	0.00545	CbGeAlD
Doxepin—CYP2C19—blood—acquired immunodeficiency syndrome	0.000347	0.00528	CbGeAlD
Doxepin—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000345	0.00525	CbGeAlD
Doxepin—ADRA1A—blood—acquired immunodeficiency syndrome	0.000343	0.00521	CbGeAlD
Doxepin—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.00034	0.00517	CbGeAlD
Doxepin—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000339	0.00515	CbGeAlD
Doxepin—HTR2B—nervous system—acquired immunodeficiency syndrome	0.000337	0.00512	CbGeAlD
Doxepin—HTR2A—retina—acquired immunodeficiency syndrome	0.000331	0.00504	CbGeAlD
Doxepin—KCNH2—blood—acquired immunodeficiency syndrome	0.000331	0.00503	CbGeAlD
Doxepin—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000327	0.00498	CbGeAlD
Doxepin—ADRA2C—blood—acquired immunodeficiency syndrome	0.000327	0.00497	CbGeAlD
Doxepin—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.000326	0.00496	CbGeAlD
Doxepin—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.000324	0.00493	CbGeAlD
Doxepin—SLC6A2—lung—acquired immunodeficiency syndrome	0.000323	0.00492	CbGeAlD
Doxepin—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000322	0.00489	CbGeAlD
Doxepin—KCNH2—bone marrow—acquired immunodeficiency syndrome	0.00032	0.00487	CbGeAlD
Doxepin—KCNH2—spinal cord—acquired immunodeficiency syndrome	0.000319	0.00485	CbGeAlD
Doxepin—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000315	0.00479	CbGeAlD
Doxepin—KCNH2—vagina—acquired immunodeficiency syndrome	0.000307	0.00467	CbGeAlD
Doxepin—CHRM3—nervous system—acquired immunodeficiency syndrome	0.000303	0.00461	CbGeAlD
Doxepin—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000303	0.0046	CbGeAlD
Doxepin—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000302	0.00459	CbGeAlD
Doxepin—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000299	0.00455	CbGeAlD
Doxepin—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000297	0.00452	CbGeAlD
Doxepin—ORM1—lymph node—acquired immunodeficiency syndrome	0.000295	0.00448	CbGeAlD
Doxepin—DRD2—lung—acquired immunodeficiency syndrome	0.000295	0.00448	CbGeAlD
Doxepin—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.000292	0.00444	CbGeAlD
Doxepin—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000291	0.00442	CbGeAlD
Doxepin—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000288	0.00438	CbGeAlD
Doxepin—ADRA2C—lung—acquired immunodeficiency syndrome	0.000286	0.00435	CbGeAlD
Doxepin—CHRM2—brain—acquired immunodeficiency syndrome	0.000284	0.00432	CbGeAlD
Doxepin—CYP1A2—blood—acquired immunodeficiency syndrome	0.000283	0.00431	CbGeAlD
Doxepin—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000282	0.00429	CbGeAlD
Doxepin—HRH1—digestive system—acquired immunodeficiency syndrome	0.000278	0.00424	CbGeAlD
Doxepin—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000278	0.00423	CbGeAlD
Doxepin—HTR2C—brain—acquired immunodeficiency syndrome	0.000274	0.00417	CbGeAlD
Doxepin—DRD2—nervous system—acquired immunodeficiency syndrome	0.000273	0.00415	CbGeAlD
Doxepin—CYP2C9—blood—acquired immunodeficiency syndrome	0.000269	0.00409	CbGeAlD
Doxepin—KCNH2—nervous system—acquired immunodeficiency syndrome	0.000269	0.00409	CbGeAlD
Doxepin—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000268	0.00407	CbGeAlD
Doxepin—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000265	0.00403	CbGeAlD
Doxepin—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000263	0.00399	CbGeAlD
Doxepin—ADRA2A—blood—acquired immunodeficiency syndrome	0.000261	0.00396	CbGeAlD
Doxepin—SLC6A4—brain—acquired immunodeficiency syndrome	0.00026	0.00395	CbGeAlD
Doxepin—CHRM1—brain—acquired immunodeficiency syndrome	0.000259	0.00394	CbGeAlD
Doxepin—KCNH2—central nervous system—acquired immunodeficiency syndrome	0.000259	0.00393	CbGeAlD
Doxepin—HTR2B—brain—acquired immunodeficiency syndrome	0.000257	0.00392	CbGeAlD
Doxepin—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000255	0.00388	CbGeAlD
Doxepin—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000251	0.00382	CbGeAlD
Doxepin—HTR2B—lymph node—acquired immunodeficiency syndrome	0.000249	0.00378	CbGeAlD
Doxepin—CYP1A2—lung—acquired immunodeficiency syndrome	0.000248	0.00378	CbGeAlD
Doxepin—HRH1—vagina—acquired immunodeficiency syndrome	0.000246	0.00374	CbGeAlD
Doxepin—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000242	0.00367	CbGeAlD
Doxepin—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000233	0.00354	CbGeAlD
Doxepin—HRH1—lung—acquired immunodeficiency syndrome	0.000233	0.00354	CbGeAlD
Doxepin—CHRM3—brain—acquired immunodeficiency syndrome	0.000232	0.00352	CbGeAlD
Doxepin—HTR1A—brain—acquired immunodeficiency syndrome	0.000231	0.00351	CbGeAlD
Doxepin—SLC6A2—brain—acquired immunodeficiency syndrome	0.000229	0.00348	CbGeAlD
Doxepin—ADRA2A—lung—acquired immunodeficiency syndrome	0.000228	0.00347	CbGeAlD
Doxepin—HTR2A—blood—acquired immunodeficiency syndrome	0.000222	0.00337	CbGeAlD
Doxepin—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000221	0.00336	CbGeAlD
Doxepin—ABCB1—retina—acquired immunodeficiency syndrome	0.000217	0.0033	CbGeAlD
Doxepin—HRH1—nervous system—acquired immunodeficiency syndrome	0.000215	0.00328	CbGeAlD
Doxepin—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000215	0.00327	CbGeAlD
Doxepin—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000213	0.00325	CbGeAlD
Doxepin—ADRA1A—brain—acquired immunodeficiency syndrome	0.000213	0.00323	CbGeAlD
Doxepin—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000212	0.00322	CbGeAlD
Doxepin—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000212	0.00322	CbGeAlD
Doxepin—DRD2—brain—acquired immunodeficiency syndrome	0.000208	0.00317	CbGeAlD
Doxepin—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000207	0.00315	CbGeAlD
Doxepin—HTR2A—vagina—acquired immunodeficiency syndrome	0.000205	0.00312	CbGeAlD
Doxepin—KCNH2—brain—acquired immunodeficiency syndrome	0.000205	0.00312	CbGeAlD
Doxepin—CYP3A4—blood—acquired immunodeficiency syndrome	0.000205	0.00312	CbGeAlD
Doxepin—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000204	0.0031	CbGeAlD
Doxepin—ADRA2C—brain—acquired immunodeficiency syndrome	0.000203	0.00308	CbGeAlD
Doxepin—CYP2D6—blood—acquired immunodeficiency syndrome	0.000202	0.00307	CbGeAlD
Doxepin—KCNH2—lymph node—acquired immunodeficiency syndrome	0.000198	0.00302	CbGeAlD
Doxepin—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000196	0.00298	CbGeAlD
Doxepin—HTR2A—lung—acquired immunodeficiency syndrome	0.000194	0.00295	CbGeAlD
Doxepin—HTR2A—nervous system—acquired immunodeficiency syndrome	0.00018	0.00274	CbGeAlD
Doxepin—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000173	0.00263	CbGeAlD
Doxepin—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000167	0.00253	CbGeAlD
Doxepin—HRH1—brain—acquired immunodeficiency syndrome	0.000165	0.0025	CbGeAlD
Doxepin—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000164	0.00249	CbGeAlD
Doxepin—ADRA2A—brain—acquired immunodeficiency syndrome	0.000162	0.00246	CbGeAlD
Doxepin—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00016	0.00244	CbGeAlD
Doxepin—HRH1—lymph node—acquired immunodeficiency syndrome	0.000159	0.00242	CbGeAlD
Doxepin—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000158	0.0024	CbGeAlD
Doxepin—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000156	0.00238	CbGeAlD
Doxepin—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000154	0.00235	CbGeAlD
Doxepin—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000152	0.00232	CbGeAlD
Doxepin—ABCB1—blood—acquired immunodeficiency syndrome	0.000145	0.00221	CbGeAlD
Doxepin—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000141	0.00214	CbGeAlD
Doxepin—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.00014	0.00213	CbGeAlD
Doxepin—HTR2A—brain—acquired immunodeficiency syndrome	0.000137	0.00209	CbGeAlD
Doxepin—ABCB1—vagina—acquired immunodeficiency syndrome	0.000135	0.00205	CbGeAlD
Doxepin—ABCB1—lung—acquired immunodeficiency syndrome	0.000127	0.00194	CbGeAlD
Doxepin—CYP2D6—brain—acquired immunodeficiency syndrome	0.000125	0.00191	CbGeAlD
Doxepin—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000536	CcSEcCtD
Doxepin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000534	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000534	CcSEcCtD
Doxepin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000532	CcSEcCtD
Doxepin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00012	0.000532	CcSEcCtD
Doxepin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000532	CcSEcCtD
Doxepin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000531	CcSEcCtD
Doxepin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000531	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000531	CcSEcCtD
Doxepin—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.00053	CcSEcCtD
Doxepin—Pain—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000527	CcSEcCtD
Doxepin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000527	CcSEcCtD
Doxepin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000527	CcSEcCtD
Doxepin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000527	CcSEcCtD
Doxepin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000527	CcSEcCtD
Doxepin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000526	CcSEcCtD
Doxepin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000525	CcSEcCtD
Doxepin—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000118	0.00179	CbGeAlD
Doxepin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000524	CcSEcCtD
Doxepin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000524	CcSEcCtD
Doxepin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000118	0.000524	CcSEcCtD
Doxepin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000523	CcSEcCtD
Doxepin—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000523	CcSEcCtD
Doxepin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000117	0.000522	CcSEcCtD
Doxepin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000117	0.000522	CcSEcCtD
Doxepin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000521	CcSEcCtD
Doxepin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000521	CcSEcCtD
Doxepin—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.00052	CcSEcCtD
Doxepin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.00052	CcSEcCtD
Doxepin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000519	CcSEcCtD
Doxepin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000519	CcSEcCtD
Doxepin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000518	CcSEcCtD
Doxepin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000518	CcSEcCtD
Doxepin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000518	CcSEcCtD
Doxepin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000518	CcSEcCtD
Doxepin—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000516	CcSEcCtD
Doxepin—Oxcarbazepine—ALB—acquired immunodeficiency syndrome	0.000116	0.308	CrCbGaD
Doxepin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000515	CcSEcCtD
Doxepin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000116	0.000514	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000514	CcSEcCtD
Doxepin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000513	CcSEcCtD
Doxepin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000511	CcSEcCtD
Doxepin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.00051	CcSEcCtD
Doxepin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000508	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000508	CcSEcCtD
Doxepin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000507	CcSEcCtD
Doxepin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000506	CcSEcCtD
Doxepin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000506	CcSEcCtD
Doxepin—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000506	CcSEcCtD
Doxepin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000114	0.000506	CcSEcCtD
Doxepin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000506	CcSEcCtD
Doxepin—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000113	0.00173	CbGeAlD
Doxepin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000505	CcSEcCtD
Doxepin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000113	0.000504	CcSEcCtD
Doxepin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000504	CcSEcCtD
Doxepin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000504	CcSEcCtD
Doxepin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000503	CcSEcCtD
Doxepin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000503	CcSEcCtD
Doxepin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000502	CcSEcCtD
Doxepin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000113	0.000502	CcSEcCtD
Doxepin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000502	CcSEcCtD
Doxepin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000501	CcSEcCtD
Doxepin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000501	CcSEcCtD
Doxepin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.0005	CcSEcCtD
Doxepin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000498	CcSEcCtD
Doxepin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000498	CcSEcCtD
Doxepin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000498	CcSEcCtD
Doxepin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000112	0.000498	CcSEcCtD
Doxepin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000112	0.000498	CcSEcCtD
Doxepin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000497	CcSEcCtD
Doxepin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000112	0.000497	CcSEcCtD
Doxepin—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000496	CcSEcCtD
Doxepin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000496	CcSEcCtD
Doxepin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000111	0.000495	CcSEcCtD
Doxepin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000494	CcSEcCtD
Doxepin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000494	CcSEcCtD
Doxepin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000494	CcSEcCtD
Doxepin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000493	CcSEcCtD
Doxepin—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000492	CcSEcCtD
Doxepin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000491	CcSEcCtD
Doxepin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000491	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.00049	CcSEcCtD
Doxepin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00011	0.00049	CcSEcCtD
Doxepin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000488	CcSEcCtD
Doxepin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000488	CcSEcCtD
Doxepin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000487	CcSEcCtD
Doxepin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000487	CcSEcCtD
Doxepin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000487	CcSEcCtD
Doxepin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000109	0.000486	CcSEcCtD
Doxepin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000486	CcSEcCtD
Doxepin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000109	0.000485	CcSEcCtD
Doxepin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000485	CcSEcCtD
Doxepin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000483	CcSEcCtD
Doxepin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000108	0.000482	CcSEcCtD
Doxepin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000108	0.000482	CcSEcCtD
Doxepin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000482	CcSEcCtD
Doxepin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000482	CcSEcCtD
Doxepin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000481	CcSEcCtD
Doxepin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000108	0.000481	CcSEcCtD
Doxepin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000481	CcSEcCtD
Doxepin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000108	0.000481	CcSEcCtD
Doxepin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.00048	CcSEcCtD
Doxepin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.00048	CcSEcCtD
Doxepin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000108	0.000479	CcSEcCtD
Doxepin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000107	0.000478	CcSEcCtD
Doxepin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000107	0.000478	CcSEcCtD
Doxepin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000477	CcSEcCtD
Doxepin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000477	CcSEcCtD
Doxepin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000477	CcSEcCtD
Doxepin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000476	CcSEcCtD
Doxepin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.000476	CcSEcCtD
Doxepin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000107	0.000474	CcSEcCtD
Doxepin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000106	0.000473	CcSEcCtD
Doxepin—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000473	CcSEcCtD
Doxepin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000473	CcSEcCtD
Doxepin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000106	0.000471	CcSEcCtD
Doxepin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.00047	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.00047	CcSEcCtD
Doxepin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000106	0.000469	CcSEcCtD
Doxepin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000105	0.000469	CcSEcCtD
Doxepin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000466	CcSEcCtD
Doxepin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000466	CcSEcCtD
Doxepin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000464	CcSEcCtD
Doxepin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000464	CcSEcCtD
Doxepin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000463	CcSEcCtD
Doxepin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000463	CcSEcCtD
Doxepin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000463	CcSEcCtD
Doxepin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000461	CcSEcCtD
Doxepin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000461	CcSEcCtD
Doxepin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.00046	CcSEcCtD
Doxepin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.00046	CcSEcCtD
Doxepin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000459	CcSEcCtD
Doxepin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000458	CcSEcCtD
Doxepin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000458	CcSEcCtD
Doxepin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000456	CcSEcCtD
Doxepin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000102	0.000454	CcSEcCtD
Doxepin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000454	CcSEcCtD
Doxepin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000454	CcSEcCtD
Doxepin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.000454	CcSEcCtD
Doxepin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000102	0.000453	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000452	CcSEcCtD
Doxepin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000451	CcSEcCtD
Doxepin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000449	CcSEcCtD
Doxepin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000448	CcSEcCtD
Doxepin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.0001	0.000446	CcSEcCtD
Doxepin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000445	CcSEcCtD
Doxepin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000445	CcSEcCtD
Doxepin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	9.99e-05	0.000444	CcSEcCtD
Doxepin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	9.96e-05	0.000443	CcSEcCtD
Doxepin—Asthenia—Indinavir—acquired immunodeficiency syndrome	9.95e-05	0.000442	CcSEcCtD
Doxepin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	9.94e-05	0.000442	CcSEcCtD
Doxepin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	9.94e-05	0.000442	CcSEcCtD
Doxepin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	9.92e-05	0.000441	CcSEcCtD
Doxepin—Constipation—Ritonavir—acquired immunodeficiency syndrome	9.91e-05	0.000441	CcSEcCtD
Doxepin—Pain—Ritonavir—acquired immunodeficiency syndrome	9.91e-05	0.000441	CcSEcCtD
Doxepin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	9.91e-05	0.000441	CcSEcCtD
Doxepin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	9.91e-05	0.000441	CcSEcCtD
Doxepin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	9.86e-05	0.000438	CcSEcCtD
Doxepin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	9.82e-05	0.000437	CcSEcCtD
Doxepin—Pruritus—Indinavir—acquired immunodeficiency syndrome	9.81e-05	0.000436	CcSEcCtD
Doxepin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	9.7e-05	0.000431	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	9.69e-05	0.000431	CcSEcCtD
Doxepin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	9.65e-05	0.000429	CcSEcCtD
Doxepin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	9.63e-05	0.000428	CcSEcCtD
Doxepin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	9.62e-05	0.000428	CcSEcCtD
Doxepin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	9.62e-05	0.000428	CcSEcCtD
Doxepin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	9.56e-05	0.000425	CcSEcCtD
Doxepin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	9.55e-05	0.000425	CcSEcCtD
Doxepin—Pain—Saquinavir—acquired immunodeficiency syndrome	9.54e-05	0.000424	CcSEcCtD
Doxepin—Constipation—Saquinavir—acquired immunodeficiency syndrome	9.54e-05	0.000424	CcSEcCtD
Doxepin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	9.49e-05	0.000422	CcSEcCtD
Doxepin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	9.49e-05	0.000422	CcSEcCtD
Doxepin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	9.48e-05	0.000422	CcSEcCtD
Doxepin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	9.48e-05	0.000422	CcSEcCtD
Doxepin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	9.46e-05	0.000421	CcSEcCtD
Doxepin—Rash—Zidovudine—acquired immunodeficiency syndrome	9.4e-05	0.000418	CcSEcCtD
Doxepin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	9.4e-05	0.000418	CcSEcCtD
Doxepin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	9.39e-05	0.000418	CcSEcCtD
Doxepin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	9.37e-05	0.000417	CcSEcCtD
Doxepin—Headache—Zidovudine—acquired immunodeficiency syndrome	9.34e-05	0.000415	CcSEcCtD
Doxepin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	9.27e-05	0.000412	CcSEcCtD
Doxepin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	9.25e-05	0.000411	CcSEcCtD
Doxepin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.23e-05	0.000411	CcSEcCtD
Doxepin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	9.21e-05	0.000409	CcSEcCtD
Doxepin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	9.19e-05	0.000409	CcSEcCtD
Doxepin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	9.19e-05	0.000409	CcSEcCtD
Doxepin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	9.17e-05	0.000408	CcSEcCtD
Doxepin—Dizziness—Indinavir—acquired immunodeficiency syndrome	9.17e-05	0.000408	CcSEcCtD
Doxepin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	9.16e-05	0.000407	CcSEcCtD
Doxepin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	9.16e-05	0.000407	CcSEcCtD
Doxepin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	9.12e-05	0.000406	CcSEcCtD
Doxepin—Pain—Lamivudine—acquired immunodeficiency syndrome	9.1e-05	0.000405	CcSEcCtD
Doxepin—Constipation—Lamivudine—acquired immunodeficiency syndrome	9.1e-05	0.000405	CcSEcCtD
Doxepin—ABCB1—brain—acquired immunodeficiency syndrome	9.01e-05	0.00137	CbGeAlD
Doxepin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.99e-05	0.0004	CcSEcCtD
Doxepin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	8.96e-05	0.000399	CcSEcCtD
Doxepin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8.87e-05	0.000394	CcSEcCtD
Doxepin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	8.86e-05	0.000394	CcSEcCtD
Doxepin—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.85e-05	0.000394	CcSEcCtD
Doxepin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	8.82e-05	0.000392	CcSEcCtD
Doxepin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8.82e-05	0.000392	CcSEcCtD
Doxepin—Vomiting—Indinavir—acquired immunodeficiency syndrome	8.81e-05	0.000392	CcSEcCtD
Doxepin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	8.77e-05	0.00039	CcSEcCtD
Doxepin—Rash—Indinavir—acquired immunodeficiency syndrome	8.74e-05	0.000389	CcSEcCtD
Doxepin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.73e-05	0.000388	CcSEcCtD
Doxepin—ABCB1—lymph node—acquired immunodeficiency syndrome	8.71e-05	0.00132	CbGeAlD
Doxepin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	8.7e-05	0.000387	CcSEcCtD
Doxepin—Headache—Indinavir—acquired immunodeficiency syndrome	8.68e-05	0.000386	CcSEcCtD
Doxepin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8.66e-05	0.000385	CcSEcCtD
Doxepin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	8.57e-05	0.000381	CcSEcCtD
Doxepin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	8.54e-05	0.00038	CcSEcCtD
Doxepin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	8.45e-05	0.000376	CcSEcCtD
Doxepin—Thiothixene—ALB—acquired immunodeficiency syndrome	8.42e-05	0.224	CrCbGaD
Doxepin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	8.41e-05	0.000374	CcSEcCtD
Doxepin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	8.41e-05	0.000374	CcSEcCtD
Doxepin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.33e-05	0.00037	CcSEcCtD
Doxepin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.31e-05	0.00037	CcSEcCtD
Doxepin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.29e-05	0.000369	CcSEcCtD
Doxepin—Rash—Efavirenz—acquired immunodeficiency syndrome	8.26e-05	0.000367	CcSEcCtD
Doxepin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.25e-05	0.000367	CcSEcCtD
Doxepin—Nausea—Indinavir—acquired immunodeficiency syndrome	8.23e-05	0.000366	CcSEcCtD
Doxepin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.22e-05	0.000366	CcSEcCtD
Doxepin—Headache—Efavirenz—acquired immunodeficiency syndrome	8.21e-05	0.000365	CcSEcCtD
Doxepin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8.2e-05	0.000365	CcSEcCtD
Doxepin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	8e-05	0.000356	CcSEcCtD
Doxepin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	7.97e-05	0.000354	CcSEcCtD
Doxepin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	7.93e-05	0.000353	CcSEcCtD
Doxepin—Rash—Delavirdine—acquired immunodeficiency syndrome	7.9e-05	0.000351	CcSEcCtD
Doxepin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.89e-05	0.000351	CcSEcCtD
Doxepin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.89e-05	0.000351	CcSEcCtD
Doxepin—Headache—Delavirdine—acquired immunodeficiency syndrome	7.85e-05	0.000349	CcSEcCtD
Doxepin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.84e-05	0.000349	CcSEcCtD
Doxepin—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.78e-05	0.000346	CcSEcCtD
Doxepin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.66e-05	0.000341	CcSEcCtD
Doxepin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.63e-05	0.00034	CcSEcCtD
Doxepin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	7.63e-05	0.000339	CcSEcCtD
Doxepin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	7.53e-05	0.000335	CcSEcCtD
Doxepin—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.44e-05	0.000331	CcSEcCtD
Doxepin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.38e-05	0.000328	CcSEcCtD
Doxepin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.37e-05	0.000328	CcSEcCtD
Doxepin—Rash—Ritonavir—acquired immunodeficiency syndrome	7.31e-05	0.000325	CcSEcCtD
Doxepin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.3e-05	0.000325	CcSEcCtD
Doxepin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.28e-05	0.000324	CcSEcCtD
Doxepin—Headache—Ritonavir—acquired immunodeficiency syndrome	7.26e-05	0.000323	CcSEcCtD
Doxepin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7.09e-05	0.000315	CcSEcCtD
Doxepin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	7.04e-05	0.000313	CcSEcCtD
Doxepin—Rash—Saquinavir—acquired immunodeficiency syndrome	7.03e-05	0.000313	CcSEcCtD
Doxepin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.03e-05	0.000313	CcSEcCtD
Doxepin—Headache—Saquinavir—acquired immunodeficiency syndrome	6.99e-05	0.000311	CcSEcCtD
Doxepin—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.88e-05	0.000306	CcSEcCtD
Doxepin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.77e-05	0.000301	CcSEcCtD
Doxepin—Rash—Lamivudine—acquired immunodeficiency syndrome	6.71e-05	0.000298	CcSEcCtD
Doxepin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.7e-05	0.000298	CcSEcCtD
Doxepin—Headache—Lamivudine—acquired immunodeficiency syndrome	6.67e-05	0.000297	CcSEcCtD
Doxepin—Clomipramine—ALB—acquired immunodeficiency syndrome	6.66e-05	0.177	CrCbGaD
Doxepin—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.63e-05	0.000295	CcSEcCtD
Doxepin—Nortriptyline—ALB—acquired immunodeficiency syndrome	6.51e-05	0.173	CrCbGaD
Doxepin—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.32e-05	0.000281	CcSEcCtD
Doxepin—Amitriptyline—ALB—acquired immunodeficiency syndrome	4.51e-05	0.12	CrCbGaD
Doxepin—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.52e-05	0.000258	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.52e-05	0.000258	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.52e-05	0.000258	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.51e-05	0.000257	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.51e-05	0.000256	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.5e-05	0.000256	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.5e-05	0.000256	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.5e-05	0.000255	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.5e-05	0.000254	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000254	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000254	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.49e-05	0.000253	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.49e-05	0.000253	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000253	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000252	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.48e-05	0.000252	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000252	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.48e-05	0.000251	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000251	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.48e-05	0.000251	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.47e-05	0.00025	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.47e-05	0.00025	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.47e-05	0.00025	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.46e-05	0.000249	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.46e-05	0.000248	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.45e-05	0.000247	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.45e-05	0.000246	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.44e-05	0.000244	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.43e-05	0.000243	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.4e-05	0.000238	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.4e-05	0.000238	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.4e-05	0.000237	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.39e-05	0.000236	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.39e-05	0.000236	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.38e-05	0.000234	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.37e-05	0.000233	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.37e-05	0.000233	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.37e-05	0.000233	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.37e-05	0.000233	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.37e-05	0.000233	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.37e-05	0.000232	CbGpPWpGaD
Doxepin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.36e-05	0.000232	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.36e-05	0.000231	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.36e-05	0.000231	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.00023	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.00023	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.35e-05	0.00023	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.35e-05	0.00023	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.35e-05	0.000229	CbGpPWpGaD
Doxepin—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.35e-05	0.000229	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.35e-05	0.000229	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.000229	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.34e-05	0.000229	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.34e-05	0.000229	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.34e-05	0.000229	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.34e-05	0.000228	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.33e-05	0.000226	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.33e-05	0.000225	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.31e-05	0.000223	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.31e-05	0.000222	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.31e-05	0.000222	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.29e-05	0.000219	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.29e-05	0.000219	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.29e-05	0.000219	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.29e-05	0.000219	CbGpPWpGaD
Doxepin—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.27e-05	0.000216	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.27e-05	0.000216	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.26e-05	0.000215	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.25e-05	0.000213	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.25e-05	0.000213	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.25e-05	0.000212	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.25e-05	0.000212	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.24e-05	0.000211	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.24e-05	0.000211	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.24e-05	0.000211	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.24e-05	0.00021	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.23e-05	0.00021	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.23e-05	0.000209	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.23e-05	0.000209	CbGpPWpGaD
Doxepin—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.23e-05	0.000209	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.22e-05	0.000208	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.22e-05	0.000207	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.22e-05	0.000207	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.22e-05	0.000207	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.22e-05	0.000207	CbGpPWpGaD
Doxepin—HRH4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.21e-05	0.000206	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.19e-05	0.000202	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.19e-05	0.000202	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.18e-05	0.000201	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.18e-05	0.000201	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.17e-05	0.000198	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.17e-05	0.000198	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.16e-05	0.000198	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.16e-05	0.000198	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.16e-05	0.000198	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.16e-05	0.000197	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.16e-05	0.000197	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.16e-05	0.000197	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.16e-05	0.000197	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.15e-05	0.000196	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.15e-05	0.000195	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.15e-05	0.000195	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.14e-05	0.000195	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.14e-05	0.000194	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.14e-05	0.000194	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.14e-05	0.000194	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.13e-05	0.000192	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.13e-05	0.000192	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.12e-05	0.00019	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.11e-05	0.000188	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.06e-05	0.000181	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.06e-05	0.000181	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.06e-05	0.000181	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.06e-05	0.000181	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.05e-05	0.000178	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.04e-05	0.000177	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000176	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.03e-05	0.000175	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.02e-05	0.000174	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.01e-05	0.000172	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.01e-05	0.000171	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.97e-06	0.00017	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.95e-06	0.000169	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.92e-06	0.000169	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.87e-06	0.000168	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.8e-06	0.000167	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.79e-06	0.000166	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.65e-06	0.000164	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.64e-06	0.000164	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.59e-06	0.000163	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.5e-06	0.000161	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.42e-06	0.00016	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.38e-06	0.00016	CbGpPWpGaD
Doxepin—HRH2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.38e-06	0.000159	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.26e-06	0.000157	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.21e-06	0.000157	CbGpPWpGaD
Doxepin—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.16e-06	0.000156	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.06e-06	0.000154	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.03e-06	0.000153	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.01e-06	0.000153	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9e-06	0.000153	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.96e-06	0.000152	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.89e-06	0.000151	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.88e-06	0.000151	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.86e-06	0.000151	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.83e-06	0.00015	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.82e-06	0.00015	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.8e-06	0.00015	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.76e-06	0.000149	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.76e-06	0.000149	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.75e-06	0.000149	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.73e-06	0.000148	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.72e-06	0.000148	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.7e-06	0.000148	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.7e-06	0.000148	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.67e-06	0.000147	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.63e-06	0.000147	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.62e-06	0.000146	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.6e-06	0.000146	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.59e-06	0.000146	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.57e-06	0.000146	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.56e-06	0.000146	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.54e-06	0.000145	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.46e-06	0.000144	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.44e-06	0.000143	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.13e-06	0.000138	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.08e-06	0.000137	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8e-06	0.000136	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.98e-06	0.000136	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.96e-06	0.000135	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.96e-06	0.000135	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.95e-06	0.000135	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.93e-06	0.000135	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.86e-06	0.000134	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.84e-06	0.000133	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.83e-06	0.000133	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.82e-06	0.000133	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.81e-06	0.000133	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.78e-06	0.000132	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.76e-06	0.000132	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.69e-06	0.000131	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.68e-06	0.000131	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.66e-06	0.00013	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	7.64e-06	0.00013	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.28e-06	0.000124	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.23e-06	0.000123	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.19e-06	0.000122	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.14e-06	0.000121	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.12e-06	0.000121	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.82e-06	0.000116	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.78e-06	0.000115	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	6.76e-06	0.000115	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.6e-06	0.000112	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.57e-06	0.000112	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.53e-06	0.000111	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.5e-06	0.00011	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	6.2e-06	0.000105	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.14e-06	0.000104	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.11e-06	0.000104	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.54e-06	9.42e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.54e-06	9.42e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.52e-06	9.38e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.35e-06	9.1e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.32e-06	9.05e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.32e-06	9.05e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.3e-06	9e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.18e-06	8.8e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.15e-06	8.76e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.1e-06	8.66e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.07e-06	8.62e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.7e-06	7.99e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.67e-06	7.95e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.62e-06	7.86e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.61e-06	7.84e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.6e-06	7.82e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.6e-06	7.82e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.59e-06	7.8e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.58e-06	7.79e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.57e-06	7.78e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.56e-06	7.75e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.54e-06	7.72e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.53e-06	7.7e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.52e-06	7.68e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.5e-06	7.66e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	4.39e-06	7.47e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	4.29e-06	7.29e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.25e-06	7.22e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.21e-06	7.15e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.18e-06	7.11e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	4.04e-06	6.87e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.01e-06	6.81e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	4.01e-06	6.81e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.88e-06	6.59e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.84e-06	6.53e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.61e-06	6.14e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.42e-06	5.82e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.26e-06	5.54e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.15e-06	5.35e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.13e-06	5.32e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.04e-06	5.17e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3e-06	5.09e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.76e-06	4.69e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.72e-06	4.62e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.71e-06	4.61e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.7e-06	4.59e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.69e-06	4.58e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.67e-06	4.54e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.66e-06	4.52e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.64e-06	4.49e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.47e-06	4.2e-05	CbGpPWpGaD
